| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
30.04.2025 21:07:19
|
FORM 8.1(a) & (b) - Mural Oncology plc
Ap9
FORM 8.1(a) & (b)
(Opening Position Disclosure)
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE
1. KEY INFORMATION
| (a) Full name of discloser: | Mural Oncology plc |
| (b) Owner or controller of interests and short
positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. | N/A |
| (c) Name of offeror/offeree in relation to whose
relevant securities this form relates: Use a separate form for each offeror/offeree | Mural Oncology plc |
| (d) Is the discloser the offeror or the offeree? | Offeree |
| (e) Date position held: The latest practicable date prior to the disclosure | 29 April 2025 |
| (f) In addition to the company in 1(c) above, is the
discloser also making disclosures in respect
of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A” | N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Ap10
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates (Note 1)
| Class of relevant security: (Note 2) | ||||
| Interests | Short positions | |||
| Number | % | Number | % | |
| (1) Relevant securities owned and/or controlled: | NIL | - | NIL | - |
| (2) Cash-settled derivatives: | NIL | - | NIL | - |
| (3) Stock-settled derivatives (including options) and agreements to purchase/ sell: | NIL | - | NIL | - |
| Total: | NIL | - | NIL | - |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. INTERESTS AND SHORT POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE
| Details of any interests and short positions (including directors’ and other employee options) of any person acting in concert with the party making the disclosure: | |||||
| a) | The directors of the Offeree detailed in the table below (together with their connected persons under Rule 3.3(b)(ii) of Part A of the Irish Takeover Rules) have the following interests in the Offeree | ||||
| Director | Class of Relevant Security | Number of ordinary shares held at midnight on 29 April 2025 | Percentage of total issued share capital (rounded) | Total number of ordinary shares underlying outstanding stock options, restricted share units and other subscription rights | |
| Caroline Loew | Ordinary shares of US$0.01 each | 43,622 | 0.25% | 865,908 | |
| Scott Jackson | Ordinary shares of US$0.01 each | ? | ? | 23,483 | |
| Francis Cuss | Ordinary shares of US$0.01 each | ? | ? | 23,483 | |
| George Stanley Golumbeski | Ordinary shares of US$0.01 each | ? | ? | 15,334 | |
| Benjamin Hickey | Ordinary shares of US$0.01 each | ? | ? | 23,483 | |
| Sachiyo Minegishi | Ordinary shares of US$0.01 each | ? | ? | 15,335 | |
| TOTAL | - | 43,622 | 0.25% | 967,026 | |
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
Ap11
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: |
| Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none” |
None |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
None |
(c) Attachments
| Is a Supplemental Form 8 attached? | YES/NO |
| No |
| Date of disclosure: | 30 April 2025 |
| Contact name: | Maiken Keson-Brookes |
| Telephone number: | +1 781 614 0239 |
Public disclosures under Rule 8.1 of the Rules must be made to a Regulatory Information Service.
Ap12
NOTES ON FORM 8.1(a) and (b)
1. See the definition of "interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules.
2. See the definition of "relevant securities” in Rule 2.1 of Part A of the Rules.
3. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.
Nachrichten zu Mural Oncology PLC Registred Shs
|
02.05.25 |
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc (EQS Group) | |
|
29.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc (EQS Group) | |
|
23.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc (EQS Group) | |
|
17.04.25 |
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc (EQS Group) |
Analysen zu Mural Oncology PLC Registred Shs
3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
📌 Thales Group (FR0000121329)
📌 Assicurazioni Generali (IT0000062072)
📌 Swiss Life Holding (CH0014852781)
➡️ Ausserdem zeigen wir, welche Aktien das Portfolio verlassen haben und warum:
❌ Meta Platforms (US30303M1027)
❌ LPL Financial (US50212V1008)
❌ American Express (US0258161092)
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Mural Oncology PLC Registred Shs | 2.62 | 1.27% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Zoll-Hoffnungen: SMI geht stärker ins Wochenende -- DAX schliesst über 23'000-Punkte-Marke -- Wall Street letztlich im Plus -- Asiens Börsen gehen mit Zuwächsen ins WochenendeAm letzten Handelstag der Woche zogen sowohl der heimische als auch der deutsche Leitindex an. Die US-Börsen konnten auch zulegen. Unterdessen ging es an den Aktienmärkten in Fernost am Freitag ebenfalls nach oben.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |